In vivo osteogenic durability of cultured bone in porous ceramics: A novel method for autogenous bone graft substitution

Transplantation

Volumn 69, Issue 1, 2000, Pages 128-134

  Yoshikawa, Takafumi ^a   Ohgushi, Hajime ^a   Nakajima, Hiroshi ^a   Yamada, Eiji ^a   Ichijima, Kunio ^a   Tamai, Susumu ^a   Ohta, Tomohiro ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b TEIJIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BOVINE SERUM ALBUMIN; DEXAMETHASONE; FLUOROCHROME; GLYCEROL 2 PHOSPHATE; HYDROXYAPATITE;

ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MATRIX; BONE TRANSPLANTATION; CERAMICS; HISTOLOGY; IMPLANT; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL;

EID: 0034650787     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001150-00022     Document Type: Article

References (39)

1. de Boer HH. The history of bone grafts. Clin Orthop 1988; 226: 292.
2. Schratt HE, Regel G, Kiesewetter B, Tscherne H. HIV infection caused by cold preserved bone transplants. Unfallchirurg 1996; 99: 679.
3. Ohgushi H, Goldberg VM, Caplan AI. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 1989; 7: 568.
4. Yoshikawa T, Ohgushi H, Okumura M, et al. Osteogenic capacity of bone marrow cells in porous beta-tricalcium phosphate: biochemical and histological analysis of bone formation; biomaterials-tissue interface. Adv Biomater, 1990; 10: 385.
5. Yoshikawa T, Suwa Y, Ohgushi H, Tamai S, Ichijima K. Self-setting hydroxyapatite cement as a carrier for bone-forming cells. Biomed Mater Eng 1996; 6 (5): 345.
6. Yoshikawa T, Ohgushi H, Okumura M, Tamai S, Dohi Y, Moriyama T. Biochemical and histological sequences of membranous ossification in ectopic site. Calcif Tissue Int 1992; 50: 184.
7. Inoue K, Ohgushi H, Yoshikawa T, et al. The effect of aging on bone formation in porous hydroxyapatite: biochemical and histological analysis. J Bone Miner Res 1997; 12: 989.
8. Goshima J, Goldberg VM, Caplan AI. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop 1991; 269: 274.
9. Allay JA, Dennis JE, Haynesworth SE, et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther 1997; 8: 1417.
10. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and ceramic. Acta Orthop Scand 1989; 60: 334.
11. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from marrow of young adult rats. Cell Tissue Res 1988; 254: 317.
12. Davies JE, Ottensmeyer P, Shen X, Hashimoto M, Peel SAF. Early extracellular matrix synthesis. In: Davies JE, ed. The bone-biomaterial interface. Toronto: University of Toronto Press,1991; 214.
13. Davies JE, Chernecky R, Lowenberg B, Shiga A. Deposition and resorption of calcified matrix in vitro by rat marrow cells. Cells Mater 1991; 1: 3.
14. Davies JE, Lowenberg B, Shiga A. The bone-titanium interface in vitro. J Biomed Mater Res 1990; 24: 1289.
15. Yao K-L, Todescan R Jr, Sodek J. Temporal changes in matrix protein synthesis and m-RNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 1994; 9: 231.
16. Yoshikawa T, Peel SA, Gladstone JR, Davies JE. Biochemical analysis of the response in rat bone marrow cell cultures to mechanical stimulation. Biomed Mater Eng 1997; 7: 369.
17. Lowenberg B, Chernecky R, Shiga A, Davies JE. Mineralized matrix production by osteoblasts on solid titanium in vitro by rat marrow cells. Cells Mater 1991; 1: 177.
18. Yoshikawa T, Ohgushi H, Dohi Y, Davies JE. Viable bone formation in porous hydroxyapatite: marrow-derived in vitro bone on the surface of ceramics. Biomed Mater Eng 1997; 7: 49.
19. Holmes RE, Bucholz RW, Mooney V. Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects: a histometric study. J Bone Joint Surg 1986; 68-A: 904.
20. White E, Shors EC. Biomaterials aspects of Interpore-200 porous hydroxyapatite. Dent Clin North Am 1986; 30: 49.
21. Reddi AH, Sullivan NS. Matrix-induced endochindral bone differentiation: influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 1980; 107: 1291.
22. Ohta T, Azuma Y, Kiyoki M, et al. Measurement of intact rat osteocalcin in osteoblast (ROS17/2.8) cells and in ovariectomized rats with a sandwich enzyme immunoassay. Calcif Tissue Int 1996; 59: 283.
23. Inoue K, Ohgushi H, Yoshikawa T, et al. Measurement of intact bone Gla protein contents in porous hydroxyapatite. Bioceramics 1995; 8: 99.
24. Fujiwara K, Yasuno M, Kitagawa T. Immunoassay for pepleomycin, a new bleomycin analog. Cancer Res 1981; 41: 4121.
25. Yoshikawa T, Ohgushi H, Tamai S. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 1996; 32: 481.
26. Yoshikawa T, Ohgushi H, Tamai S. Rapid bone formation by grafting cultured bone in porous hydroxyapatite. Bioceramics 1995; 8: 421.
27. Parfitt AM. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. I. mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism 1976; 25: 809.
28. Gurevitch O, Fabian I. Ability of the hemopoietic microenvironment in the induced bone to maintain the proliferative potential of early hemopoietic precursors. Stem Cells 1993; 11: 56.
29. Pinholt EM, Solheim E, Talsnes O, Larsen TB, Bang G, Kirkeby OJ. Revascularization of calvarial, mandibular, tibial, and iliac bone grafts in rats. Ann Plast Surg 1994; 33: 193.
30. Miclau T, Lindsey RW, Probe R, Rahn BA, Perren SM. Autogenous cancellous bone graft incorporation in a gap defect in the canine femur. J Orthop Trauma 1996; 10: 108.
31. Walch G, Badet R, Nove-Josserand L, Levigne C. Nonunions of the surgical neck of the humerus: surgical treatment with an intramedullary bone peg, internal fixation, and cancellous bone grafting. J Shoulder Elbow Surg 1996; 5: 161.
32. Yoshikawa T, Ohgushi H, Akahane M, Tamai S, Ichijima K. Analysis of gene expression in osteogenic hydroxyapatite composite implanted at heterotopic sites. J Biomed Mater Res 1998; 41: 568,.
33. de Bruijin JD, vd Brink I, Bovell YP. Development of human bone marrow culture to examine the interface between apatite and bone formed in vitro, Bioceramics 1996; 9: 45.
34. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81.
35. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278.
36. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295.
37. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997; 21: 225.
38. Ohgushi H, Okumura M. Osteogenic of rat and human marrow cells in porous ceramics: experimental in athymic (nude) mice. Acta Orthop 1990; 61: 431.
39. Yoshikawa T, Ohgushi H, Uemura T, et al. Human marrow cells-derived cultured bone in porous ceramics. Biomed Mater Eng 1998; 8: 311.